Regulation of hdm2 by Stress-Induced hdm2alt1 in Tumor and Nontumorigenic Cell Lines Correlating with p53 Stability
Open Access
- 1 October 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (19), 9467-9473
- https://doi.org/10.1158/0008-5472.can-05-3013
Abstract
Alternative and aberrant splicing of hdm2 occurs in tumor and normal tissues. However, the factors that induce these splice variants and whether they are translated to protein products in vivo is unknown, making it difficult to decipher which of these hdm2 transcripts have a normal physiologic function or contribute to carcinogenesis. We investigated the conditions that induce this post-transcriptional modification of hdm2 in tumor and nontumorigenic cell lines. We showed that UV and γ radiation as well as cisplatin treatment induced alternative splicing of hdm2, which resulted in a single splice variant, hdm2alt1, irrespective of the cell type. Interestingly, the mechanism of UV-induced splicing is independent of p53 status. Immunoanalysis revealed that, after UV radiation, HDM2ALT1 protein was expressed and interacted with HDM2 that correlated to increased p53 protein levels and its accumulation in the nucleus, whereas HDM2 localized more to the cytoplasm with a decrease in its RNA and protein level. We propose that stress-induced HDM2ALT1 regulates HDM2 at two levels, RNA and protein, further modulating the p53-HDM2 interaction or interactions of HDM2 with other cell cycle regulatory proteins. This kind of regulation may possibly restrict oncogenic functions of HDM2 and contribute to the many protective responses triggered by certain stress signals. Our data imply that HDM2ALT1 possesses a normal physiologic function in damaged cells, perhaps facilitating cellular defense. (Cancer Res 2006; 66(19): 9467-73)Keywords
This publication has 20 references indexed in Scilit:
- Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation InhibitionMolecular and Cellular Biology, 2004
- Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAsGene, 2004
- An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and TumorigenesisPublished by Elsevier BV ,2004
- Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down‐regulation of the p53 response after multiple types of DNA damageThe FASEB Journal, 2003
- ARF Function Does Not Require p53 Stabilization or Mdm2 RelocalizationMolecular and Cellular Biology, 2002
- An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2Oncogene, 2001
- p53-Independent Down-Regulation of Mdm2 in Human Cancer Cells Treated with AdriamycinMolecular Cell Biology Research Communications, 2000
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Role of two upstream open reading frames in the translational control of oncogene mdm2Oncogene, 1999
- Genomic organization of the mouse double minute 2 geneGene, 1996